Prisma Health

Running trials

• Recruiting

  Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  NCT07562152· Phase 3· Source

• Recruiting

  Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  NCT07326566· Phase 2· Source

• Recruiting

  Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

  NCT06651177· Phase 2· Source

• Recruiting

  A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  NCT07085104· Phase 1· Source

• Recruiting

  Virtue® SAB in the Treatment of Coronary ISR Trial

  NCT07045194· Source

• Recruiting

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  NCT07207811· Phase 3· Source

• Recruiting

  MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

  NCT05908331· Source

• Recruiting

  Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

  NCT06001788· Phase 1· Source

• Recruiting

  Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

  NCT06190717· Source

• Recruiting

  SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

  NCT06001827· Source

• Recruiting

  A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

  NCT06150157· Phase 1· Source

• Active, not recruiting

  Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)

  NCT05763407· Source

• Active, not recruiting

  Assessment of Combined CCM and ICD Device in HFrEF

  NCT05855135· Source

• Active, not recruiting

  A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension

  NCT05203510· Phase 4· Source

• Active, not recruiting

  A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

  NCT05141721· Phase 2/3· Source

• Recruiting

  X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma

  NCT04389281· Phase 1· Source

• Active, not recruiting

  Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

  NCT04140526· Phase 1/2· Source

• Recruiting

  Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

  NCT04174157· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease2 recruiting
• Coronary artery disease2 recruiting
• Acute myeloid leukemia1 recruiting
• Amyloidosis1 recruiting
• Glioblastoma1 recruiting
• Head and neck cancer1 recruiting
• Heart failure1 recruiting
• Lupus (SLE)1 recruiting
• Melanoma1 recruiting
• Metastatic breast cancer1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Pancreatic cancer1 recruiting
• Sarcoma1 recruiting
• Spinal muscular atrophy1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  VAPorized Administration of Bumetanide for Outpatient Relief in Heart Failure

  NCT07375212· Phase 4· Source

• Recruiting

  Thrombectomy Using Pulsed Aspiration for Reperfusion of Brain Occlusions

  NCT06029491· Source

• Completed

  The Effects of Drug Candidate CS1 on Lung Structure and Function Utilizing FRI

  NCT06907693· Source

• Terminated

  STOP-T1D Low-Dose (ATG)

  NCT04291703· Phase 2· Source

• Recruiting

  Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure

  NCT05650541· Source

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Source

• Completed

  Virtual Mindfulness Training for Adults With History of Depression

  NCT05347719· Source

• Terminated

  Study of MT-6402 in Subjects With Advanced Solid Cancer That Expresses PD-L1

  NCT04795713· Phase 1· Source

• Completed

  Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers

  NCT03748186· Phase 1· Source